. PCA score plots with quality control (QC) cluster. Plots show spectra of metabolites in (A) positive (R 2 X = 0.652, and Q 2 = 0.488) and (B) negative (R 2 X = 0.699, and Q 2 = 0.482) modes of UPLC-QTOF-MS. CIN1: cervical intraepithelial neoplasia 1, CIN2/3: cervical intraepithelial neoplasia 2 or 3, CX CAN: cervical cancer. 
. PCA score plots with quality control (QC) cluster. Plots show spectra of metabolites in (A) positive (R 2 X = 0.652, and Q 2 = 0.488) and (B) negative (R 2 X = 0.699, and Q 2 = 0.482) modes of UPLC-QTOF-MS. CIN1: cervical intraepithelial neoplasia 1, CIN2/3: cervical intraepithelial neoplasia 2 or 3, CX CAN: cervical cancer. Figure S2 . Construction of the altered metabolism pathways using MetPA. (a) Alanine, aspartate and glutamate metabolism (colored metabolites C00049: aspartate, C00152: asparagine, C00041: alanine, C00022: pyruvate, C00064: glutamine, C00025: glutamate); (b) Arginine and proline metabolism (colored metabolotes: C00300: creatine, C00791: creatinine, C00062: arginine, C00049: aspartate, C00064: glutamine, C00327: citrulline, C00077: ornithine, C00025: glutamate, C00148: proline, C00022: pyruvate); (c) Taurine and hypotaurine metabolism (colored metabolites C00245: taurine, C00041: alanine, C00022: pyruvate); (d) Pyruvate metabolism (colored metabolites C00149: malate, C00186: lactate, C00022: pyruvate). Colors of the metabolites from yellow to red represent different level of significance, whereas light blue color represents that these metabolites are not in data set and are used as background for enrichment analysis. 
